文献速递主动脉外科

马凡综合征A型主动脉夹层行冻结象鼻联合全弓置换的远期结局

Long-term outcomes of frozen elephant trunk for type A aortic dissection in patients with Marfan syndrome.
PubMed 文献 · J Thorac Cardiovasc Surg · 2017-06-16

该回顾性队列分析106例马凡综合征合并A型主动脉夹层患者,均行冻结象鼻(FET)联合全弓置换(TAR)。手术死亡率6.6%,5年生存率86.6%、免于再手术率88.8%;围术期行根部处理者生存更优,Bentall手术与再手术风险升高相关。

要点

  • FET+TAR治疗马凡综合征A型夹层手术死亡率6.6%,远期生存与免于再手术率良好。
  • 围术期行根部处理与更高远期生存相关(P=.047)。
  • Bentall手术是远期再手术的危险因素(OR 12.012,P=.046)。

核心结论

  • FET联合TAR可安全用于马凡综合征A型主动脉夹层,手术死亡率低且远期生存与免于再手术率良好。
  • 同期Bentall手术预示更好远期生存但增加远期再手术风险。

研究设计与样本

  • 回顾性分析106例马凡综合征患者(平均年龄34.5±9.7岁)行FET+TAR治疗A型主动脉夹层。
  • 随访完整率97.0%(96/99),平均随访6.3±2.8年。

主要发现

  • 手术死亡率6.6%(7/106),脊髓损伤和卒中各1例(0.9%),因出血再探查6例(5.7%)。
  • 院内死亡或并发症的唯一危险因素为解剖外旁路(OR 7.120,95%CI 1.018-49.790,P=.048)。
  • 急性A型夹层较慢性者远期死亡风险更低(OR 0.112,95%CI 0.021-0.587,P=.048)。
  • 12例远期再手术,包括胸腹主动脉修复8例、TEVAR处理远端新发破口3例、冠状动脉吻合口修复1例。
  • 5年生存率86.6%(95%CI 77.9%-92.0%),免于再手术率88.8%(95%CI 80.1%-93.4%);8年分别为74.1%(95%CI 61.9%-83.0%)和84.2%(95%CI 72.4%-91.2%)。

关键数值与推荐

  • 竞争风险分析:5年、8年、10年死亡率分别为4%、18%、25%,再手术率分别为10%、15%、15%,无再手术生存率分别为86%、67%、60%。
  • 围术期行根部处理者生存显著更高(P=.047)。
  • 再手术危险因素:诊断至手术天数(OR 1.160,95%CI 1.043-1.289,P=.006)和Bentall手术(OR 12.012,95%CI 1.041-138.606,P=.046)。

临床怎么用

  • 对马凡综合征A型夹层可考虑FET+TAR,需关注解剖外旁路增加围术期风险。
  • 同期根部处理可能改善远期生存,但Bentall手术需警惕远期再手术风险。
  • 急性期手术可能降低远期死亡风险,应尽早干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The use of the frozen elephant trunk (FET) technique for repair of type A aortic dissection (TAAD) in Marfan syndrome (MFS) is controversial. We seek to evaluate the efficacy of FET and total arch replacement (TAR) for TAAD in patients with MFS. METHODS: The early and long-term outcomes were analyzed for 106 patients with MFS (mean age, 34.5 ± 9.7 years) undergoing FET + TAR for TAAD. RESULTS: Operative mortality was 6.6% (7 of 106). Spinal cord injury and stroke occurred in 1 patient each (0.9%), and reexploration for bleeding occurred in 6 patients (5.7%). Extra-anatomic bypass was the sole risk factor for operative mortality and morbidity (odds ratio [OR], 7.120; 95% confidence interval [CI], 1.018-49.790; P = .048). Follow-up was complete in 97.0% (96 of 99), averaging 6.3 ± 2.8 years. Late death occurred in 17 patients. Patients with acute TAAD were less prone to late death than those with chronic TAAD (OR, 0.112; 95% CI, 0.021-0.587; P = .048). Twelve patients required late reoperation, including thoracoabdominal aortic repair in 8, thoracic endovascular aortic repair for distal new entry in 3, and coronary anastomotic repair in 1. At 5 years, survival was 86.6% (95% CI, 77.9%-92.0%) and freedom from reoperation was 88.8% (95% CI, 80.1%-93.4%), and at 8 years, survival was 74.1% (95% CI, 61.9%-83.0%) and freedom from reoperation was 84.2% (95% CI, 72.4%-91.2%). In competing risks analysis, mortality was 4% at 5 years, 18% at 8 years, and 25% at 10 years; the respective rates of reoperation were 10%, 15%, and 15%; and the respective rates of survival without reoperation were 86%, 67%, and 60%. Survival was significantly higher in patients who underwent root procedures during FET + TAR (P = .047). Risk factors for reoperation were days from diagnosis to surgery (OR, 1.160; 95% CI, 1.043-1.289; P = .006) and Bentall procedure (OR, 12.012; 95% CI, 1.041-138.606; P = .046). CONCLUSIONS: The frozen elephant trunk and total arch replacement procedure can be safely performed for TAAD in MFS with low operative mortality, favorable long-term survival and freedom from reoperation. A concomitant Bentall procedure was predictive of better long-term survival and increased risk for late reoperation. These results argue favorably for the use of the FET + TAR technique in the management of TAAD in patients with MFS.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Ma WG, Zhang W, Zhu JM, et al. Long-term outcomes of frozen elephant trunk for type A aortic dissection in patients with Marfan syndrome. J Thorac Cardiovasc Surg. 2017. PMID: 28797584. doi:10.1016/j.jtcvs.2017.04.088

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。